Close Menu

NEW YORK – NuProbe Global, a spinout from Harvard University's Wyss Institute, has merged with China's CarrierGene Biotech and has partnered with Illumina to develop clinical molecular diagnostic tests for genetic disorders.

The firm will continue to operate as NuProbe in the US and offer target enrichment assays for next-generation sequencing-based diagnostic tests based on toehold probes. Financial and other details of the merger were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.